Form 4: Zai Lab Director William Lis Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Director William Lis of Zai Lab Ltd. sold a portion of his holdings in American Depositary Shares (ADS) under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On July 1, 2024, William Lis, a director of Zai Lab Ltd., sold 10,297 American Depositary Shares (ADS) at a weighted average price of $17.3139 per share, with prices ranging from $17.02 to $17.96.
- An additional 100 ADS were sold at $18.04 per share on the same day.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on March 1, 2024.
- Following these sales, Lis directly owns 53,089 ADS.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions under a pre-existing trading plan, without indicating any specific positive or negative outlook.
Industry Context
Sales by company insiders are a common occurrence, and the use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on any specific non-public information.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of adoption of Rule 10b5-1 trading plan |
| 07/01/2024 | Date of ADS transactions |
| 07/03/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.